SCHEMBL7356299

SCHEMBL7356299

Cc1cc(S(C)(=O)=O)ccc1[O]

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
ENPP2 Q13822 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
G6PD P11413 1/20 0.42
IDE P14735 1/20 0.42
ALDH1A1 P00352 1/20 0.41
PTGS2 P35354 5/20 0.40
AKR1C3 P42330 2/20 0.40
AKR1C2 P52895 2/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL758951 0.81 LMNA (0.64) LMNATDP1ENPP2SMN1; SMN2G6PD
SCHEMBL6143116 0.80 LMNA (0.42) LMNATDP1ALDH1A1PTGS2
SCHEMBL11144160 0.80 SNCA (0.47) LMNATDP1SMN1; SMN2ALDH1A1
SCHEMBL12638410 0.80 PTGS2 (0.58) LMNAALDH1A1PTGS2
SCHEMBL6182053 0.77 L3MBTL1 (0.61) LMNATDP1ENPP2SMN1; SMN2G6PD
SCHEMBL24574571 0.76 LMNA (0.42) LMNATDP1ENPP2SMN1; SMN2G6PD
SCHEMBL29421567 0.76 LMNA (0.49) LMNATDP1ENPP2SMN1; SMN2G6PD
SCHEMBL4639254 0.76 G6PD (0.60) LMNATDP1ENPP2SMN1; SMN2G6PD
SCHEMBL2329775 0.76 PTGS2 (0.64) LMNASMN1; SMN2ALDH1A1PTGS2
SCHEMBL394533 0.76 LMNA (0.49) LMNATDP1ENPP2SMN1; SMN2G6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054877-A1 NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-11-29 EP disclosed
WO-1999041246-A1 NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1999-08-19 WO disclosed